Lebwohl David Insider Trades

Insider Trading History

Track insider trading activity for Lebwohl David. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Medical Officer
Holding Value $1.71M 131,192 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$333k 24,147 shares
$13.78
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Medical Officer
Holding Value $1.58M 121,249 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$110k 11,903 shares
$9.21
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Medical Officer
Holding Value $1.7M 130,866 shares
Last Trade
Mar 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$623k 61,714 shares
$10.09
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Medical Officer
Holding Value $1.14M 87,666 shares
Last Trade
Jan 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$116k 9,557 shares
$12.18
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Jan 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$37.2k 3,189 shares
$11.66
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Medical Officer
Holding Value $1.27M 97,223 shares
Last Trade
Jan 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$37.2k 3,189 shares
$11.66
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Medical Officer
Holding Value $1.21M 93,073 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.82M 55,855 shares
$32.66
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Medical Officer
Holding Value $708k 54,372 shares
Last Trade
Jan 03, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$172k 5,843 shares
$29.46
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Medical Officer
Holding Value $784k 60,215 shares
Last Trade
Jan 01, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$97.2k 3,187 shares
$30.49
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Medical Officer
Holding Value $41.5k 3,189 shares
Last Trade
Jan 01, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$97.2k 3,187 shares
$30.49
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Medical Officer
Holding Value $734k 56,361 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.77M 43,342 shares
$40.75
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Medical Officer
Holding Value $334k 25,687 shares
Last Trade
Jan 04, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$95.8k 2,574 shares
$37.21
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Medical Officer
Holding Value $368k 28,261 shares
Last Trade
Jan 01, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$111k 3,187 shares
$34.89
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Medical Officer
Holding Value $83k 6,376 shares
Last Trade
Jan 01, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$111k 3,187 shares
$34.89
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Medical Officer
Holding Value $263k 20,203 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.61M 20,203 shares
$79.85
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Medical Officer
Holding Value $322k 24,738 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.21M 27,632 shares
$79.85
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Medical Officer
Holding Value $125k 9,563 shares
Last Trade
Jan 01, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$377k 3,187 shares
$118.24
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Medical Officer
Holding Value $142k 10,922 shares
Last Trade
Jan 01, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$118k 1,051 shares
$112.24
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Medical Officer
Holding Value $156k 11,973 shares
Last Trade
Jan 01, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$377k 3,187 shares
$118.24
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Medical Officer
Holding Value $129k 9,914 shares
Last Trade
Nov 05, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$319k 2,400 shares
$132.73
$13.02

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up